Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

July
28
2017

How to Get Rid of a Keloid Scar

If you have keloid scars on your skin, we understand just how frustrating, annoying, and sometimes embarrassing this can be. Keloid scars can be painful and itchy, varying in degrees of sensation from person-to-person, interrupting…

July
26
2017

Medical device company taps into 1.4 billion-person market with deal in China

Boca Raton medical device maker Sensus Healthcare has been cleared to expand operations in China, bringing its skin-treatment technology to a country with more than 1.4 billion people. Sensus Healthcare (NASDAQ: SRTS) has made a name for itself…

July
26
2017

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids

BOCA RATON, Fla., July 26, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the…

July
25
2017

Sensus Healthcare to Host Second Quarter 2017 Financial Results and Business Update Conference Call on August 3, 2017

BOCA RATON, Fla., July 25, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that management…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy